November 30, 2016
Advance in Chronic Kidney Disease 2016
Renal Research Institute (Miami, FL; January, 2016)  


Debate: Early start of renal replacement therapy in AKI is preferred over later start date
Edward G Clark, MD

Mineralocorticoid receptor antagonists in ESRD: Efficacy and Safety
Andrew Bomback, MD

Management of diabetics with CKD under the perspective of new drugs
George Bakris, MD

Brigham Renal Board Review Course 2015
(Boston, MA, August, 2015)  


Late Post-Transplant Medical Complications
Leonardo V. Riella, MD

the Renal Research Institute

19th International Conference in Dialysis: Advances in CKD 2017

February 1-3, 2017. Caesar's Palace, Las Vegas, Nevada.
Click here to view program information or register on-line!

Please visit the Renal Research Institute Website .


Impact of optimal medical therapy in the dual antiplatelet therapy study (Circulation)
Physical activity and anger or emotional upset as triggers of acute myocardial infarction. The INTERHEART Study (Circulation)
Dietary flaxseed reduces central aortic blood pressure without cardiac involvement but through changes in plasma oxylipins (Hypertens)
Estrogen signaling in the adrenal cortex. implications for blood pressure sex differences (Hypertens)
Developmental programming of hypertension: physiological mechanisms (Hypertens)
Body mass index predicts 24-hour urinary aldosterone levels in patients with resistant hypertension (Hypertens)
Revisiting fibromuscular dysplasia. rationale of the European Fibromuscular Dysplasia Initiative (Hypertens)
Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis (Am J Clin Nutr)
The validity of left ventricular mass as a surrogate end point for all -cause and cardiovascular mortality outcomes in people with CKD: a systematic review and meta-analysis (Am J Kidney Dis)
High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: an RCT (Am J Kidney Dis)
The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: a systematic review and meta-analysis (Am J Kidney Dis)
Ergocalciferol treatment does not improve erythropoietin utilization and hospitalization rate in hemodialysis patients (BMC Nephrol)
Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta -analysis (BMC Nephrol)
Gastrointestinal bleeding in the community: The Atherosclerosis Risk in Communities (ARIC) Study (Clin J Am Soc Nephrol)
Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration (Hemodial Int)
Proton pump inhibitors and risk of incident CKD and progression to ESRD (J Am Soc Nephrol)
Efficacy of folic acid therapy on the progression of chronic kidney disease. The Renal Substudy of the China Stroke Primary Prevention Trial (JAMA Intern Med)
Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease (Kidney Int)
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping (Kidney Int)
Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system (Am J Clin Nutr)
Prevention of contrast-associated acute kidney injury: what should we do? (Am J Kindey Dis)
Correction of metabolic acidosis improves insulin resistance in chronic kidney disease (BMC Nephrol)
Effect of patiromer on urinary ion excretion in healthy adults (Clin J Am Soc Nephrol)
Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury (Kidney Int)
Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly (Nephrol Dial Transplant)


 H: Drug therapy -- ACE inhibitors
Angiotensin Receptor Blockers Confer Cardioprotection in Males but Not in Females with Type 2 Diabetes
 H: Special problems -- Endocrine hypertension
Thyroid Functional Disease and Mortality in U.S. Veterans with Chronic Kidney Disease
 H: Special problems -- Smoking, ethanol, substance abuse
Cigarette Smoking Partially Negates the Kidney Protective Effect of ACE Inhibition in Stage 2, Non-Diabetic, Hypertension-Associated CKD
 H: Special problems -- Obesity, Insulin Resistance
Morbid Obesity and Time to Transfer to Hemodialysis among Incident Peritoneal Dialysis Patients

 Basic hemodialysis -- Vascular Access: venous
Patient First: The Survival Benefit of Fistula First, Catheter Last in Hemodialysis is Primarily due to Patient Selection
 Basic hemodialysis -- Adequacy, prescription, urea kinetics
High Efficiency Hemodiafiltration (HDF) versus Hemodialysis (HD): A Comparison of Clinical Outcomes in EuroDOPPS
 Basic hemodialysis -- Complications (acute)
Improving Interdialytic Weight Gain in Dialysis Patients
 Basic hemodialysis -- (Intermittent) dialysis for ARF
Effects of Intensive SBP Lowering on Incident Chronic Kidney Disease (CKD) and Cardiovascular (CV) Outcomes in Non-CKD Subgroup in Systolic Blood Pressure Intervention Trial (SPRINT)
 Basic hemodialysis -- Home hemodialysis
The End-Stage Renal Disease Prospective Payment System Had Little Effect on Home Dialysis Usage in the United States
 Basic hemodialysis -- New dialysis methods, hemodiafiltration
Rapid Iterative Development of Blood Conduits for Artificial Kidney Eliminates Thrombosis
 Basic peritoneal dialysis -- Peritonitis and exit-site infection
Peritoneal Dialysis-Related Infection Rates and Outcomes: Early Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
 CRF by problem area -- Cost effectiveness, CQI, Guidelines
Variability in Peritoneal Dialysis Patients' Training: The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
 CRF: Problem areas -- Pre-ESRD care, initiation of dialysis
Changing Phenotype of CKD in Diabetes Mellitus (DM) and Its Implications
 CRF by problem area -- Progression
Folic Acid Therapy Delays the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial (CSPPT)
Effect of Folic Acid Supplementation on the New-Onset Proteinuria: New Insight from a Randomized Controlled Trial
Exercise Training in Hypertensive Patients with Chronic Kidney Disease: A Randomized Controlled Trial
BP Levels Lower Than 120-70 mm Hg Associate with Lower Risk of Renal Events in Type I Diabetes
Intensified Multifactorial Intervention in Type 2 Diabetes and Microalbuminuria Reduces End Stage Renal Disease and Mortality: 21 Years Follow-Up of the Steno-2 Study
Intensive Blood Pressure Control Associates with Lower Mortality Risk among Persons with High-Risk APOL1 Genotype
 CRF by organ system -- Nutrition, Inflammation
BMI Trajectory with Decline in Kidney Function: Results from the CRIC Study
Intradialytic Protein Supplementation Increases Protein Intake in Older, but Not Younger, Hemodialysis Patients and Is Associated with Improved Hip Bone Mineral Density
 CRF by problem area -- Anemia/Erythropoietin/Iron
Dose Requirements, Hospitalization, and Mortality Are Similar with Subcutaneous versus Intravenous Erythropoietin Administration
Anemia and Iron Management over the First 5 Years after Dialysis Start: Results from the DOPPS
 CRF by problem area -- Bone disease/Ca-P/PTH
Cholecalciferol Supplementation to Correct Hypovitaminosis D in Peritoneal Dialysis Patients Increases FGF23 but Not Other Osteogenic Proteins: A Randomized Clinical Trial
Progression of Medial Arterial Calcification in End-Stage Renal Diseaase
Small Vessel and Soft Tissue Histology in End-Stage Renal Disease: Specificity of Diagnostic Criteria for Calciphylaxis
 CRF by organ system -- HEENT
Olfactory and Nutritional Impairment in Patients with Kidney Disease: Assessment and Intervention
 CRF by organ system -- Lungs
Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study
 CRF by organ system -- Cardiovascular/Hypertension
eGFR, Albuminuria, and Future Risk of Peripheral Artery Disease: The Chronic Kidney Disease Prognosis Consortium
ESRD and Mortality after Medical Therapy Compared with Percutaneous and Surgical Coronary Revascularization in Individuals with CKD at Low, Medium, or High Cardiovascular Risk
Continuous ECG Recording of Cardiac Rhythm Shows That Pre-Hemodialysis (HD) Potassium (K+) Levels Need To Be Tightly Controlled between 4 to 5.5 mM
 CRF by organ system -- Neurological
Cognitive Function and Kidney Disease: Baseline Data from the SPRINT Trial
Serum Bicarbonate Level and Cognitive Dysfunction in Hypertensive Adults with and Without CKD
 CRF by organ system -- Skin
Time Course of Reduction in Itch Intensity during and following Treatment with Nalbuphine ER Tablets: A Randomized, Placebo-Controlled Trial in Patients with Uremic Pruritus

 Assessing renal function -- Creatinine clearance
Equations Based on a Set of Novel Metabolites Markers Provide a More Precise Determination of the Glomerular Filtration Rate (GFR) Than the Standard Equations in a Swedish Population with Measured GFR
Saliva Urea Nitrogen Dipstick: A Simple Tool to Detect and Stratify Risk of Renal Disease in Low Resource Settings
 Acid-base/Lytes -- Metabolic acidosis
Women Have Higher Urine pH Than Men due to Increased Gastrointestinal (GI) Alkali Absorption
 Acid-base/Lytes -- Hypomagnesemia
Dietary Magnesium Supplementation Prevents and Reverses Vascular and Soft Tissue Calcifications in Uremic Rats
 ARF etiology -- Hemolytic/uremic syndrome and TTP
Eculizumab in Secondary Atypical Hemolytic Uremic Syndrome
 ARF etiology -- Multiple myeloma
Treatment of Myeloma Cast Nephropathy: A Randomized Trial Comparing Intensive Hemodialysis with High Cutoff or Standard High-Flux Dialyzers (The MYRE Study)
European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy (EuLITE): Survival and Renal Outcomes
 Proteinuria/Hematuria -- Vasculitis (Wegener's PAN, etc.)
Rapid Onset of Action of Orally Administered C5aR Inhibitor CCX168 in Randomized Clinical Trial in ANCA-Associated Vasculitis (CLEAR)
 Cystic disease -- Hereditary polycystic disease
Copeptin, a Surrogate for Vasopressin, Predicts Disease Progression and Tolvaptan Treatment Efficacy in ADPKD. Results of the TEMPO 3:4 Trial
A New Clinical Entity: GANAB-Related Polycystic Kidney and Liver Disease
 Nephrolithiasis -- Renal Stones: Etiology
Comparison of Furosemide/Fludrocortisone with Ammonium Chloride Test in the Diagnosis of Incomplete dRTA in Recurrent Stone Formers: A Prospective Study
 Transplant -- Transplantation
Efficacy and Safety of 3 Different Treatment Regimen in De Novo Renal Transplant Patients: 5 Year Follow-Up Data of the HERAKLES Trial on Everolimus-Based Immunosuppression
Timing of Eculizumab Treatment and the Need for Dialysis in Patients with aHUS Who Receive a Kidney Transplant
Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients
Identification of Urinary mRNA Expression for Diagnosing Acute Rejection by Meta-Analysis of Gene Expression in Kidney Transplantation
20-Year Trends in Clinical Outcomes of Kidney Transplantation